DELFI Diagnostics
DELFI's AI and whole-genome sequencing platform detects cancer-associated cfDNA fragmentation patterns in the blood.
153 employees · est. 2019 · Palo Alto, United States
23Strands is the older company (2018 vs 2019); DELFI Diagnostics is the larger of the two.
Side-by-Side Comparison
| Metric | 23Strands | DELFI Diagnostics |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2019 |
| Headquarters | ||
| Headquarters | Australia | Palo Alto, United States |
| Employees | ||
| Employees | 29 | 153 larger |
| Industry | ||
| Industry | AI, Big Data, Biotechnology | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | $10.00K | $330.50M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Whole Genome Sequencing, Genomic Health Analysis, Fertility23 Program, Medical Record Integration, Precision Health Insights, Concierge Health Pathway | Cancer Detection Solutions, Liquid Biopsy Diagnostics, Clinical Trial Services, Research and Innovation in Fragmentomics, Machine Learning Application in Genomic Sequencing |
| Target Customers | ||
| Target Customers | Clinicians, Healthcare Providers, Patients with Unexplained Infertility, Reproductive Health Specialists, Medical Researchers | Healthcare Providers, Patients, Pharmaceutical Companies, Biotech Researchers, Hospital Systems |
| Taxonomy | ||
| Taxonomy | Whole Human Genome Sequencing, Genomics, Integrated Medical Records, Health Improvements, Clinical Insights, Big Data Processing, Evidence-based Recommendations, Personalized Medicine, Disease Risk Assessment, Medication Optimization, Healthcare Innovation, Genetic Testing, DNA Analysis | Cancer Detection, Early Detection, Genome Sequencing, DNA Fragmentation, Medical Technology, Healthcare Innovation |
| Website | ||
| Website | 23strands.com | delfidiagnostics.com |
About 23Strands
23Strands, with its slogan "23Strands is unlocking the power of your DNA," is an Australia-based startup leveraging advancements in AI, Big Data, Biotechnology, Health Care, and Machine Learning to innovate in the realm of genetic analysis. Founded in 2018, the company aims to redefine Whole Human...
About DELFI Diagnostics
DELFI Diagnostics, founded in 2019, is at the forefront of the convergence of AI and biotechnology, focusing on health care through early cancer detection. Their slogan, "Saving lives through early cancer detection," encapsulates their mission of leveraging artificial intelligence and whole genome s...
We will tell you when either one moves
BounceWatch watches 23Strands and DELFI Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 23Strands and DELFI Diagnostics — by email.
Frequently Asked Questions
Compare 23Strands with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at 23Strands on 15 Jun 2026, and DELFI Diagnostics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
